AMRYT PHARMA PLC - SPNR ADR (AMYT)
US03217L1061 - ADR
AMRYT PHARMA PLC - SPNR ADR
NASDAQ:AMYT (4/11/2023, 7:09:37 PM)
After market: 14.7 0 (0%)14.7
+0.01 (+0.07%)
Company Profile
Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The firm is focused on developing and commercialization of treatments for orphan and rare diseases patients. The Company’s commercial business provides orphan disease products, which includes Juxtapid/ Lojuxta and Myalept / Myalepta. The Company’s lead development candidate is FILSUVEZ.
Company Info
AMRYT PHARMA PLC - SPNR ADR
Ivybridge House, 1 Adam Street
London D02 CR98
P: 442034155730.0
CEO: Dr. Joseph A. Wiley
Employees: 99
Website: https://www.amrytpharma.com/
AMYT News
a year ago - ChiesiChiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc/PRNewswire/ -- Chiesi Farmaceutici S.p.A. ("Chiesi"), an international, research-focused biopharmaceuticals and healthcare group, today announced the...
a year ago - Amryt Pharma plcChiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma PlcChiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc Acquisition positions Chiesi to expand patient access to approved treatments and...
a year ago - Amryt Pharma plcHigh Court of Justice of England and Wales Sanctions Scheme of Arrangementa year ago - Amryt Pharma plcAmryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi FarmaceuticiAmryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici Transaction Expected to Close in Q2 2023 Dublin, Ireland, March 22,...
AMYT Twits
Here you can normally see the latest stock twits on AMYT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
